Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Takeuchi

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2009
The significance of adaptive design in r&d in JapanMasahiro Takeuchi
BMC Medical Research Methodology|February 23, 2024
Treatment effect estimation using the propensity score in clinical trials with historical controlSaki Kanamori, Masahiro Takeuchi
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 7, 2012
Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studiesTakeshi Fuji, Mashio Nakamura, Masahiro Takeuchi
Nature Reviews. Clinical Oncology|April 25, 2009
Reasons for response differences seen in the V15-32, INTEREST and IPASS trialsNagahiro Saijo, Masahiro Takeuchi, Hideo Kunitoh
Journal of the American Chemical Society|September 22, 2005
Polymer-micelle incarcerated scandium as a polymer-supported catalyst for high-throughput organic synthesisMasahiro Takeuchi, Ryo Akiyama, Shu Kobayashi
Journal of Biopharmaceutical Statistics|June 23, 2004
Observation of time-dependent adverse events and the influence of drop-out thereon in long-term safety studies--simulation study under the current practice of post-marketing safety evaluation in JapanMamoru Narukawa, Akifumi Yafune, Masahiro Takeuchi
Journal of Biopharmaceutical Statistics|February 26, 2010
Prediction of an outcome using trajectories estimated from a linear mixed modelNami Maruyama, Fumiaki Takahashi, Masahiro Takeuchi
Contemporary Clinical Trials|March 29, 2007
Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazideYoshiharu Horie, Jitsuo Higaki, Masahiro Takeuchi
Lung|February 22, 2012
Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trialsKouichi Inoue, Mamoru Narukawa, Masahiro Takeuchi
Statistics in Medicine|September 4, 2008
An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotesTakashi Funatogawa, Ikuko Funatogawa, Masahiro Takeuchi
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2009
The significance of adaptive design in r&d in JapanMasahiro Takeuchi
BMC Medical Research Methodology|February 23, 2024
Treatment effect estimation using the propensity score in clinical trials with historical controlSaki Kanamori, Masahiro Takeuchi
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 7, 2012
Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studiesTakeshi Fuji, Mashio Nakamura, Masahiro Takeuchi
Nature Reviews. Clinical Oncology|April 25, 2009
Reasons for response differences seen in the V15-32, INTEREST and IPASS trialsNagahiro Saijo, Masahiro Takeuchi, Hideo Kunitoh
Journal of the American Chemical Society|September 22, 2005
Polymer-micelle incarcerated scandium as a polymer-supported catalyst for high-throughput organic synthesisMasahiro Takeuchi, Ryo Akiyama, Shu Kobayashi
Journal of Biopharmaceutical Statistics|June 23, 2004
Observation of time-dependent adverse events and the influence of drop-out thereon in long-term safety studies--simulation study under the current practice of post-marketing safety evaluation in JapanMamoru Narukawa, Akifumi Yafune, Masahiro Takeuchi
Journal of Biopharmaceutical Statistics|February 26, 2010
Prediction of an outcome using trajectories estimated from a linear mixed modelNami Maruyama, Fumiaki Takahashi, Masahiro Takeuchi
Contemporary Clinical Trials|March 29, 2007
Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazideYoshiharu Horie, Jitsuo Higaki, Masahiro Takeuchi
Lung|February 22, 2012
Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trialsKouichi Inoue, Mamoru Narukawa, Masahiro Takeuchi
Statistics in Medicine|September 4, 2008
An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotesTakashi Funatogawa, Ikuko Funatogawa, Masahiro Takeuchi
Pageof 19